These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3534756)

  • 21. [Multicenter study of the in vitro effect of imipenem (N-formimidoyl-thienamycin) on hospital bacteria].
    Soussy CJ; Otterbein G; Le Van Thoi J; Thabaut A; Meyran M; Courtieu AL; Reynaud A; Dabernat H; Lareng MB; Chanal M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):487-92. PubMed ID: 3911142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro activity of ceftizoxime on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Deforges L; Le Van Thoi J; Thabaut A; Meyran M; Chanal M; Cluzel M; Brun Y; Coulet M; Fleurette J
    Pathol Biol (Paris); 1984 May; 32(5):326-30. PubMed ID: 6330645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bactericide activity of sulbactam before bacteria belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex].
    Villar HE; Laurino G; Hoffman M
    Enferm Infecc Microbiol Clin; 1996 Nov; 14(9):524-7. PubMed ID: 9035707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro effect of antibiotics against hospital strains of Acinetobacter baumanii].
    Hercouet H; Bousser J; Donnio PY; Avril JL
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):612-6. PubMed ID: 2797884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antibiotic sensitivity of Acinetobacter calcoaceticus in patients with infected burns].
    Borisova OK; Makarenkova RV; Bogatova IS; Kutsidi EV
    Antibiotiki; 1982 Jun; 27(6):447-50. PubMed ID: 7114831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN
    Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
    Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Selection of resistance mutants and bacteriostatic and bactericidal activity of meropenem and imipenem against Acinetobacter spp].
    Villar HE; Laurino G; Arena MF; Hoffman M
    Enferm Infecc Microbiol Clin; 1997 Mar; 15(3):140-3. PubMed ID: 9235053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic.
    Boo TW; Walsh F; Crowley B
    J Antimicrob Chemother; 2006 Nov; 58(5):1101-2. PubMed ID: 16916867
    [No Abstract]   [Full Text] [Related]  

  • 30. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.
    Vahaboglu H; Budak F; Kasap M; Gacar G; Torol S; Karadenizli A; Kolayli F; Eroglu C
    J Antimicrob Chemother; 2006 Sep; 58(3):537-42. PubMed ID: 16816400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro bacteriostatic activity of cefmenoxime (SCE 1365), cefotaxime and moxalactam].
    Husson MO; Bryskier A; Izard D; Leclerc H
    Pathol Biol (Paris); 1983 May; 31(5):347-50. PubMed ID: 6312395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin.
    Dibb WL; Asphaug Kjellevold V; Digranes A
    Chemotherapy; 1983; 29(5):332-6. PubMed ID: 6311491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital.
    Santos-Ferreira MO; Vital JO
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():23-6. PubMed ID: 3469195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Activity of imipenem and meropenem against strains of Acinetobacter baumannii isolated from various Chilean hospitals].
    Bello H; Domínguez M; Sepúlveda M; Cerda F; González G; Mella S; Zemelman R
    Rev Esp Quimioter; 2000 Dec; 13(4):405-7. PubMed ID: 11498708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Concerning the sensitivity of Acinetobacter calcoaceticus.
    Jedlicková Z; Tesaríková E; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(1):73-6. PubMed ID: 2351822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Problem of treatment for pyo-inflammatory complications caused by Acinetobacter].
    Bogomolova NS; Bol'shakov LV; Kuznetsova SM
    Anesteziol Reanimatol; 2014; (1):26-32. PubMed ID: 24749305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ro 17-2301: in vitro comparison with aztreonam, imipenem, ceftazidime, cefotaxime and netilmicin.
    Digranes A; Dibb WL; Benonisen E; Salveson A
    Chemotherapy; 1985; 31(4):279-85. PubMed ID: 3928281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Phenotypes of resistance to antibiotics of Acinetobacter baumannii. Impact on therapeutic orientation].
    Ygout JF; Pasteau C; Mugnier P; Berlioux J; Daguet GL
    Pathol Biol (Paris); 1988 Mar; 36(3):245-9. PubMed ID: 3283688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.